Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Thoraco-laparoscopic partial esophagogastrectomy.
- Who it may be relevant to
- Registry conditions: Esophageal Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Early and Intermediate Term Outcomes of Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer
Overview
Thoraco-laparoscopic partial esophagogastrectomy has emerged as a promising minimally invasive alternative, combining thoracoscopy and laparoscopy to reduce the trauma associated with open surgery.Early and intermediate-term outcomes provide critical information on both the oncological efficacy and functional benefits of the procedure. By examining recurrence rates within the first 12-24 months, this study will provide valuable insights into the oncological robustness of this approach compared to more invasive approaches.
Interventions
- Procedure Thoraco-laparoscopic partial esophagogastrectomy
1. Laparoscopic Phase: * The stomach is mobilized, and a part of it is resected to include the lower esophageal segment. * Left gastric nodes, the splenic and common hepatic nodes are dissected. * A gastric tube is created using endoscopic staplers for esophageal reconstruction and fixed to the proximal gastrectomy specimen using sutures 2. Thoracoscopic Phase: * The patient is positioned in prone position * Three small incisions are made in the thorax * Further esophageal mo
Primary outcome measures
- Immediate Postoperative complications [Time frame: first month post operative]
- Dysphagia [Time frame: Collected at base line preoperative,one month, and 12 months post-surgery.]
- resection margin status [Time frame: 2 weeks postoperative]
- lymph node yield. [Time frame: first month post operative]
- regurgitation [Time frame: Collected at one month, and 12 months post-surgery.]
Secondary outcome measures (3)
- recurrence rate [Time frame: first year post operative]
- body mass index [Time frame: Collected at base line preoperative,one month, and 12 months post-surgery.]
- serum albumin [Time frame: Collected at base line preoperative,one month, and 12 months post-surgery.]
Eligibility criteria
Inclusion criteria
- Patients diagnosed with resectable esophageal cancer (stages I-III).
- Suitable for thoraco-laparoscopic partial esophagogastrectomy.
- Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
Exclusion criteria
- Presence of distant metastasis at diagnosis.
- History of previous esophageal or gastric surgery.
- Contraindications to laparoscopy or thoracoscopy.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Sohag Faculty of Medicine — Sohag
Identifiers
NCT: NCT06879483 · Soh-Med-25-2-5MD